Nexstim

Nexstim company information, Employees & Contact Information

Explore related pages

Related company profiles:

Nexstim is a Finnish, globally operating medical technology company. Founded in 2000 in Helsinki, Finland, Nexstim is committed to improving the quality of life of patients with significant unmet clinical needs. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders. Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain. SmartFocus® technology is used in Nexstim’s proprietary Navigated Brain Therapy (NBT®) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT® system is CE marked for the treatment of major depression and chronic neuropathic pain. In addition, Nexstim is commercializing its SmartFocus® based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on Nasdaq First North Growth Market Finland.

Company Details

Employees
54
Founded
-
Address
Elimäenkatu 9 B, Helsinki,fi-00510,finland
Phone
358927271717
Email
in****@****tim.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Helsinki
Looking for a particular Nexstim employee's phone or email?

Nexstim Questions

News

Hospital in Finland Orders Nexstim NBS 6 System - TradingView

Hospital in Finland Orders Nexstim NBS 6 System TradingView

Can Nexstim Plc (5NX) stock resist broad market declines - July 2025 Weekly Recap & Weekly Top Stock Performers List - Fundação Cultural do Pará

Can Nexstim Plc (5NX) stock resist broad market declines - July 2025 Weekly Recap & Weekly Top Stock Performers List Fundação Cultural do Pará

Nexstim : Business Update Q3 2025 - MarketScreener

Nexstim : Business Update Q3 2025 MarketScreener

Nexstim Receives NBS 6 System Order from US Customer - TradingView

Nexstim Receives NBS 6 System Order from US Customer TradingView

What To Expect From Nexstim Oyj (OHEL:NXTMH) Q2 2025 Earnings - Yahoo Finance

What To Expect From Nexstim Oyj (OHEL:NXTMH) Q2 2025 Earnings Yahoo Finance

Private Medical Center in Finland Orders Nexstim NBS 6 System - TradingView

Private Medical Center in Finland Orders Nexstim NBS 6 System TradingView

Sinaptica Announces Initiation of Co-Development of the SinaptiStim® Precision Neuromodulation System to treat Alzheimer’s Disease; On Track for Pivotal Clinical Trial Initiation in 2025 - Yahoo Finance

Sinaptica Announces Initiation of Co-Development of the SinaptiStim® Precision Neuromodulation System to treat Alzheimer’s Disease; On Track for Pivotal Clinical Trial Initiation in 2025 Yahoo Finance

Top 10 Deep Brain Stimulation Device Companies | Provides Best Devices - Market.us Media

Top 10 Deep Brain Stimulation Device Companies | Provides Best Devices Market.us Media

Nexstim (HEL:NXTMH) soars 12% this week, taking five-year gains to 358% - simplywall.st

Nexstim (HEL:NXTMH) soars 12% this week, taking five-year gains to 358% simplywall.st

Nexstim Receives System Order from US Clinic - TradingView

Nexstim Receives System Order from US Clinic TradingView

Nexstim pilot study shows boost for depression symptoms - Clinical Trials Arena

Nexstim pilot study shows boost for depression symptoms Clinical Trials Arena

Is Nexstim Plc (5NX) stock undervalued by metrics - July 2025 Macro Moves & Real-Time Buy Zone Alerts - newser.com

Is Nexstim Plc (5NX) stock undervalued by metrics - July 2025 Macro Moves & Real-Time Buy Zone Alerts newser.com

NBT System Gets FDA Clearance for Depression Treatment - Neurology Advisor

NBT System Gets FDA Clearance for Depression Treatment Neurology Advisor

Nexstim releases the NBS 6 for diagnostic use in the United States - TradingView

Nexstim releases the NBS 6 for diagnostic use in the United States TradingView

Interview with Nexstim’s CEO Mikko Karvinen - Analyst Group

Interview with Nexstim’s CEO Mikko Karvinen Analyst Group

Nexstim launches NBT major depressive disorder TMS treatment device in US - MassDevice

Nexstim launches NBT major depressive disorder TMS treatment device in US MassDevice

Correction: Insider information: Nexstim’s NBS 6 diagnostics system receives MDR certification in the EU - TradingView

Correction: Insider information: Nexstim’s NBS 6 diagnostics system receives MDR certification in the EU TradingView

Nexstim Plc: Invitation to the Annual General Meeting - Arvopaperi

Nexstim Plc: Invitation to the Annual General Meeting Arvopaperi

Nexstim's NBS 6 Diagnostics System Receives MDR Certification in the EU - MarketScreener

Nexstim's NBS 6 Diagnostics System Receives MDR Certification in the EU MarketScreener

Nexstim First Half 2025 Earnings: Misses Expectations - simplywall.st

Nexstim First Half 2025 Earnings: Misses Expectations simplywall.st

Nexstim: getting into peoples’ heads - Helsinki Times

Nexstim: getting into peoples’ heads Helsinki Times

Top Nexstim Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant